Industry news

• A resource for anti-tumor drugs testing has been launched in Russia

  23 March 2023 GxPnews

  BioVitrina, Russia’s new online resource, is an electronic database on biological samples of patients with oncological diseases. The service was developed at the world-class research center “Digital Biodesign and Personalized Healthcare”, Izvestia reports.

• Building a Community of Trust in Epilepsy & Rare Syndromes

  23 March 2023 Brad Chapman / FiercePharma

  Just like those first few hours, our organization focuses on listening to epilepsy and rare syndromes communities so we can understand the unmet needs, evolve, and do everything in our power to help. Throughout my first year in this role, I’ve taken these insights and experiences to build out a framework for our efforts moving forward – with patients and caregivers at the center. 

• MHRA approves prostate cancer combination therapy

  22 March 2023 Catherine Eckford / European Pharmaceutical Review

  The first PARP inhibitor to show clinical benefit with a new hormonal agent in first-line metastatic castration-resistant prostate cancer has been granted UK approval.

• Return of the megaround: Is biotech back from the brink?

  22 March 2023 Annalee Armstrong / FierceBiotech

  $100 million for Rapport Therapeutics. $112 million for Noema Pharma. $108 million for Bicara Therapeutics. The megaround has come roaring back in the past few weeks, but is biotech really healing? 

• MHRA to trial stem cell robot for cell therapies

  21 March 2023 Catherine Eckford / European Pharmaceutical Review

  The second-ever stem cell-producing robot, being tested by the UK MHRA, could produce safer, cost-effective treatments for diseases like cancer.

• Mass spectrometry software can link different data types

  20 March 2023 Catherine Eckford / European Pharmaceutical Review

  A new version of an open-source software is the first tool with an entire data processing pipeline that integrates LC-IMS-MS and MALDI-IMS-MS imaging data.

• Rostec will supply measles vaccine to the regions for clean-up immunization

  20 March 2023 GxPnews

  Russia is launching nation-wide vaccination against measles in April 2023. By the end of the year, Natsimbio holding (part of Rostec) will supply 800,000 doses of monocomponent vaccine produced by NPO Microgen to the regions of the Russian Federation for the vaccination campaign, the press service of the state corporation reports.

• SibSMU is building a preclinical research center that complies with the GLP standard

  17 March 2023 GxPnews

  The creation of a preclinical research center at the Siberian State Medical University (SibSMU) has begun in Tomsk. The site will be the only such center in the region that complies with the GLP state standard, Yevgeny Kulikov, the rector of the university, said at a meeting in the Tomsk Region Administration on Monday. It is planned that the modernization will be completed within one to three years.

• Ministry of Health: the situation with permits for drug trials is coming back to normal

  16 March 2023 GxPnews

  After a plunge, the number of permits issued for drug trials in Russia is leveling out. According to Sergey Glagolev, Deputy Head of the Ministry, the decrease in the number of permits issued for international multicenter clinical trials was compensated by the growth of local trials.

• Novel small molecule drug facilitates leukaemia remission

  16 March 2023 Catherine Eckford / European Pharmaceutical Review

  Leukaemia patients went into remission when given a novel drug containing a small molecule that inhibits menin and MLL1 interaction, a study showed.